Menu
  • About RedHill
  • Products
  • Partnering
  • Investors
  • News
  • Contact
  • CAREERS
  • Press Releases

    Date Summary View
    Toggle Summary Egalet and RedHill Biopharma enter into License Agreement
    Egalet and RedHill Biopharma enter into an exclusive license agreement to develop, and commercialize Egalet’s EG-P042 (Carvedilol) for the treatment of certain cardiac diseases ...
    View HTML
    Toggle Summary SCOLR Pharma and RedHill Biopharma enter into Licensing Agreement
    SCOLR Pharma, Inc. Enters into Worldwide Licensing Agreement with RedHill Biopharma Ltd. ...
    View HTML
    Toggle Summary IntelGenx and RedHill Announce Definitive Agreement
    IntelGenx and RedHill Announce Definitive Agreement for Anti-Migraine Film Product ...
    View HTML
    Toggle Summary Giaconda Completes Sale of 3 Products to RedHill Biopharma
    Sale of patents brings significant cash injection into Giaconda<br> Giaconda stands to benefit if the patents are successfully commercialised ...
    View HTML
    Toggle Summary RedHill Biopharma Raises $3.5M in a Private Placement
    The Company Reports the Closing of Two Transactions and the Possibility of an IPO ...
    View HTML
    Toggle Summary IntelGenx Exhibits VersaFilm Triptan (RHB-103) Poster at CPhl Paris View HTML
    Toggle Summary RedHill Announces Successful Completion of $10m Financing - 3 Times More than Originally Planned View HTML
    Toggle Summary (Hebrew) RedHill Announces Successful Completion of $10m Financing - 3 Times More than Originally Planned View HTML
    Toggle Summary (Hebrew) RedHill Biopharma Announces Successful IPO on the Tel Aviv Stock Exchange View HTML
    Toggle Summary RedHill Biopharma Announces Successful IPO on the Tel Aviv Stock Exchange View HTML